tiprankstipranks
Advertisement
Advertisement

Vanguard Total Stock Market ETF (VTI) Daily Update—2/13/26

Story Highlights

Let’s take a quick look at how the Vanguard Total Stock Market ETF (VTI) has been doing recently.

Vanguard Total Stock Market ETF (VTI) Daily Update—2/13/26

The Vanguard Total Stock Market ETF (VTI), which tracks the broader U.S. stock market, is up 0.38% in early trading on Friday. VTI’s three-month average trading volume stands at 5.30 million shares. Over the past five days, the ETF recorded $442 million in net inflows, signaling continued investor interest. Overall, VTI is down 0.62% over the past five days, but up 1.85% year-to-date.

Claim 30% Off TipRanks

Forget margin or options. Here's how the pros trade AMZN

VTI’s Top Holdings

Currently, VTI holds 3,467 stocks with total assets worth $590.73 billion. Its top positions are:

VTI’s Dividend

VTI pays a quarterly dividend of $0.951 per share, reflecting a 1.1% yield, and carries an expense ratio of 0.03%.

VTI’s Price Forecasts and Holdings

According to TipRanks’ unique ETF analyst consensus, determined based on a weighted average of analyst ratings on its holdings, VTI is a Moderate Buy. The Street’s average price target of $420.53 implies an upside of 24.64%. 

Currently, VTI’s five holdings with the highest upside potential are:

  1. Quince Therapeutics (QNCX)
  2. Bioatla (BCAB)
  3. MetaVia (MTVA)
  4. NRX Pharmaceuticals (NRXP)
  5. Reviva Pharmaceuticals Holdings (RVPH)

Meanwhile, its holdings with the greatest downside potential are:

  1. Rallybio (RLYB)
  2. ImageneBio (IMA)
  3. Loews (L)
  4. Valaris (VAL) 

Notably, VTI ETF’s Smart Score is seven, implying that this ETF is likely to perform in line with the broader market.

Power up your ETF investing with TipRanks. Discover the Best AIETFs, carefully curated based on TipRanks’ analysis.

Disclaimer & DisclosureReport an Issue

1